Key result
One cycle of intravenous chemotherapy markedly reduced the intracardiac tumor burden and resolved presenting symptoms in a 49-year-old man with cardiac Burkitt lymphoma.
Case Report (n=1)
No
Cardiac imaging is crucial for diagnosing systemic illness such as Burkitt lymphoma presenting as intracardiac masses and for monitoring the response to chemotherapy.
May support prompt chemotherapy in rare cardiac Burkitt lymphoma; leaves open confirmation of durability and generalizability.
Malignant metastases are among the most common cardiac masses. We report a rare case of cardiac involvement by Burkitt lymphoma in a 49-year-old man who presented with a 2-month history of dyspnea and palpitations. A transthoracic echocardiogram revealed 2 intracardiac masses in the right atrium (one of which partially encased the tricuspid valve), myocardial infiltration, and pericardial disease. Results of pleural fluid cytology and flow cytometry confirmed involvement by Burkitt lymphoma. Subsequent chemotherapy markedly reduced the intracardiac tumor burden and resolved the patient's presenting symptoms. Our case highlights the importance of cardiac imaging in diagnosing systemic illness, initiating early and appropriate treatment, and monitoring disease progression in patients with intracardiac Burkitt lymphoma.
No takes yet. Share an insight, caveat, or question.
Khalid et al. (2020) conducted a case report in Burkitt lymphoma with cardiac involvement (n=1). Chemotherapy (rituximab, cyclophosphamide, vincristine, doxorubicin, methotrexate) was evaluated on Tumor burden and symptom resolution. One cycle of intravenous chemotherapy markedly reduced the intracardiac tumor burden and resolved presenting symptoms in a 49-year-old man with cardiac Burkitt lymphoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: